Summary

A Management Review Report documents the periodic evaluation of your Quality Management System (QMS) by top management. It provides a systematic assessment of QMS performance through Key Performance Indicators (KPIs), audit results, customer feedback, and process effectiveness. The report demonstrates management commitment to quality and drives strategic decisions for continuous improvement of your medical device quality system.

Why is a Management Review Report important?

The Management Review Report exists because regulatory frameworks require top management to take active responsibility for quality management system effectiveness. It’s not sufficient for management to simply approve procedures - they must regularly evaluate whether the entire quality system is working and achieving its intended outcomes.

For medical device manufacturers, the Management Review Report is crucial because it demonstrates executive oversight to regulatory authorities and notified bodies. It shows that quality decisions are made at the highest organizational level with full awareness of system performance. The report drives strategic quality planning by identifying trends, resource needs, and improvement opportunities that require management attention. Without systematic management review, you risk quality system drift, missed improvement opportunities, and regulatory findings related to inadequate management responsibility for quality.

Regulatory Context

Under 21 CFR Part 820 (Quality System Regulation):

  • Management responsibility is mandatory under Section 820.20
  • Management reviews are required under Section 820.20(c) with executive oversight
  • Must review QMS effectiveness and adequacy of resources
  • Results must drive quality planning and improvement activities

Special attention required for:

  • Management responsibility (820.20) - executives must actively participate in quality decisions
  • Quality planning (820.20(b)) - management reviews inform strategic quality planning
  • CAPA system oversight (820.100) - management must review CAPA effectiveness
  • Resource management (820.25) - reviews must address adequacy of quality resources

Guide

Your Management Review Report must systematically evaluate QMS performance and drive strategic quality decisions. The report transforms operational data into management insights that guide resource allocation and improvement priorities.

1. Overall QMS Assessment

The management review assessment provides your executive summary of quality system performance. This section requires you to synthesize information from multiple sources - audit results, KPI performance, customer feedback, and process metrics - into a clear management perspective on QMS effectiveness.

You must address whether your quality system is suitable (appropriate for your organization and products), adequate (sufficient to meet regulatory requirements), and effective (achieving intended quality outcomes). If performance meets expectations, state this clearly with supporting evidence. If improvements are needed, identify specific areas requiring management attention and resource allocation.

2. Key Performance Indicator Review

The KPI assessment table provides the detailed data that supports your overall QMS assessment. For each quality process, you must evaluate actual performance against established acceptance criteria and provide a management assessment of results.

Your KPI review should cover all critical quality processes including document control, human resources, software development, risk management, change management, customer feedback, vigilance, CAPA, deployment, validation, post-market surveillance, internal audits, clinical evaluation, regulatory updates, purchasing, sales, and usability engineering.

For each KPI, document the actual data collected during the review period, compare it to acceptance criteria, provide a management assessment of performance, identify any improvement measures needed, and evaluate the effectiveness of previous improvement measures. This systematic approach ensures comprehensive coverage of quality system performance.

3. Management Signatures and Accountability

The management review signatures section establishes clear accountability for quality decisions. You must identify the management team members who participated in the review and obtain their formal commitment to the findings and resulting actions.

Include the position, name, and signature of each management team member involved in the review. This typically includes senior executives, quality management, and other key decision-makers who have authority to allocate resources and drive organizational change. The signatures demonstrate that management has reviewed the data, understands the implications, and commits to supporting necessary improvements.

4. Review Timing and Follow-up

Document the date of review and establish clear timelines for implementing any improvement measures identified during the review. The management review should occur at planned intervals (typically annually) but may be conducted more frequently if significant quality issues arise.

Ensure that review findings are properly communicated throughout the organization and that responsible personnel understand their roles in implementing improvement measures. Plan for follow-up activities to verify that improvement measures are effective and achieving intended outcomes.

Example

Scenario: You conduct your annual management review covering the previous 12 months of QMS performance. The review shows that most KPIs are meeting acceptance criteria, but training completion rates have dropped slightly and there’s been an increase in customer feedback requiring response. Management decides to implement automated training reminders and enhance the customer feedback process to improve performance in these areas.

Complete Management Review Report Document

Management Review Report

ID: MRR-2024-001

1. Scope

This report provides the results of the management review of the quality management system (QMS) performed according to SOP Management Review. The review was conducted to assess the suitability, adequacy, and effectiveness of the QMS and to identify opportunities for improvement, if needed.

2. Management Review Assessment

Overall QMS Assessment:

The quality management system has performed effectively during the 2023 review period, with 22 of 24 key performance indicators meeting or exceeding acceptance criteria. The QMS demonstrates strong suitability for our medical device operations and adequate resource allocation to maintain regulatory compliance.

Two areas require management attention: training completion rates have decreased from 98% to 92%, and customer feedback response time has increased slightly. These issues do not indicate systemic failures but represent opportunities for process enhancement through improved automation and resource allocation.

The QMS continues to be effective in maintaining product quality, regulatory compliance, and customer satisfaction. No major changes to the quality system structure are required, but targeted improvements in training management and customer communication will enhance overall performance.

2.1 Management Signatures

Date of Review: March 20, 2024

PositionNameSignature
Chief Executive OfficerRobert ChenR. Chen
Chief Technology OfficerSarah MartinezS. Martinez
Quality ManagerDavid KimD. Kim
Regulatory Affairs ManagerJennifer LopezJ. Lopez

3. QMS and Key Performance Indicator Review

ProcessKey Performance IndicatorData on KPIManagement AssessmentImprovement MeasuresEvaluation of Previous Measures
Quality ManualAll quality objectives are met100% of objectives metQMS is effective and meets requirementsNoneN/A
Document and Record ControlArchived documents maintained for device lifetime100% of documents retainedDocument management process is effectiveNoneN/A
Document and Record ControlNo process non-conformities during external audits0 non-conformitiesDocument management process is effectiveNoneN/A
Human ResourcesInitial training completion rate for employees92% of employees completeTraining process needs improvementImplement automated training remindersPrevious manual tracking was insufficient
Integrated Software DevelopmentSoftware system testing with limited failuresFailure under 25% of testingSoftware development process is effectiveNoneN/A
Integrated Software DevelopmentKnown software anomalies lead to no adverse events0 adverse events due to known software anomaliesSoftware development process is effectiveNoneN/A
Software Problem ResolutionEfficient investigation and resolution of software problems94% of problems resolved successfullySoftware problem resolution process is effectiveNoneN/A
Risk ManagementNumber of unacceptable risks mitigated100% of unacceptable risks mitigated with risk controlsRisk management process is effectiveNoneN/A
Risk ManagementRisk controls successfully implemented100% of risk controls implementedRisk management process is effectiveNoneN/A
Change ManagementNo non-conformities due to incomplete change documentation0 non-conformitiesChange management process is effectiveNoneN/A
Feedback and Customer ManagementCustomer feedback response rate78% of feedback processedCustomer feedback process needs improvementEnhance response tracking systemPrevious informal tracking was inadequate
VigilanceIncidents reported within legal reporting deadlines100% of incidents reportedVigilance process is effectiveNoneN/A
Corrective and Preventative ActionCAPA closure rate93% of CAPAs closedCAPA process is effectiveNoneN/A
DeploymentNo deployment without prior system testing100% of deployments testedDeployment process is effectiveNoneN/A
Software ValidationSoftware validation completed for all necessary software100% of software validatedSoftware validation process is effectiveNoneN/A
Post-Market SurveillancePMS Report, PSUR, or Summary of Safety and Clinical Performance delivered within timeframe required0 late reportsPost-market surveillance process is effectiveNoneN/A
Internal AuditNumber of internal audits completed on schedule100% of audits completedInternal audit process is effectiveNoneN/A
Clinical EvaluationOn-time and as planned PMCF activitiesPMCF activities conducted on scheduleClinical evaluation process is effectiveNoneN/A
Management ReviewFrequency of management review meetings1 meeting annually completedManagement review process is effectiveNoneN/A
Update of RegulationsRegulatory updates identified and implemented within six months of publication effective datesUpdates implemented within 4 months averageRegulatory update process is effectiveNoneN/A
Product Registration and CertificationZero unsuccessful attempts of Notified Body assessment due to incomplete documentationNo failed assessments due to documentation issuesRegistration process is effectiveNoneN/A
PurchasingSupplier acceptance on surveillance8% of suppliers moved from accepted to blocked during surveillancePurchasing process is effectiveNoneN/A
SalesSales and marketing materials approved prior to use100% of materials approved prior to useSales process is effectiveNoneN/A
Usability and Human Factors EngineeringUsability testing with no failed critical tasks100% of usability critical tasks passedUsability engineering process is effectiveNoneN/A

Annex 1 - KPI Acceptance Criteria

The following acceptance criteria were used to evaluate the KPIs:

ProcessKPIAcceptance CriteriaPrimary Responsibility
Quality ManualAll quality objectives are met100% of objectives metQuality
Document and Record ControlArchived documents maintained for device lifetime100% of documents retainedQuality
Document and Record ControlNo process non-conformities during external audits0 non-conformitiesQuality
Human ResourcesInitial training completion rate for employees95% of employees completeCorporate
Integrated Software DevelopmentSoftware system testing with limited failuresFailure under 30% of testingSoftware
Integrated Software DevelopmentKnown software anomalies lead to no adverse events0 adverse events due to known software anomaliesSoftware
Software Problem ResolutionEfficient investigation and resolution of software problemsGreater than 90% of problems resolved successfullySoftware
Risk ManagementNumber of unacceptable risks mitigated100% of unacceptable risks mitigated with risk controlsQuality
Risk ManagementRisk controls successfully implemented100% of risk controls implementedQuality
Change ManagementNo non-conformities due to incomplete change documentation0 non-conformitiesQuality
Feedback and Customer ManagementCustomer feedback response rateOver 80% of feedback processedQuality
VigilanceIncidents reported within legal reporting deadlines100% of incidents reportedQuality
Corrective and Preventative ActionCAPA closure rateOver 90% of CAPAs closedQuality
DeploymentNo deployment without prior system testing100% of deployments testedSoftware
Software ValidationSoftware validation completed for all necessary software100% of software validatedSoftware
Post-Market SurveillancePMS Report, PSUR, or Summary of Safety and Clinical Performance delivered within timeframe required0 late reportsQuality
Internal AuditNumber of internal audits completed on schedule100% of audits completedQuality
Clinical EvaluationOn-time and as planned PMCF activitiesPMCF activities conducted on scheduleQuality
Management ReviewFrequency of management review meetingsAt least 1 meeting annuallyManagement
Update of RegulationsRegulatory updates identified and implemented within six months of publication effective datesUpdates implemented within 6 monthsQuality
Product Registration and CertificationZero unsuccessful attempts of Notified Body assessment due to incomplete documentationNo failed assessments due to documentation issuesQuality
PurchasingSupplier acceptance on surveillanceUnder 10% of suppliers moved from accepted to blocked during surveillanceProduct
SalesSales and marketing materials approved prior to use100% of materials approved prior to useBusiness
Usability and Human Factors EngineeringUsability testing with no failed critical tasks100% of usability critical tasks passedQuality

Q&A